Jiani Xiong

Novel recombinant immunotoxin of EGFR specific nanobody fused with cucurmosin, construction and antitumor efficiency<i>in vitro</i>

Cuimin Deng, Jiani Xiong, Xiaofan Gu et al. · Oncotarget · 2017 · 55 citations · Full text

Medicine, Oncology, Pharmacology +15

CCND1 Amplification Profiling Identifies a Subtype of Melanoma Associated With Poor Survival and an Immunosuppressive Tumor Microenvironment

Jun Liu, Jing Lin, Xuefeng Wang et al. · Frontiers in Immunology · 2022 · 22 citations · Full text

Medicine, Immunology, Oncology +17

SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy

Xiaobin Zheng, Jing Lin, Jiani Xiong et al. · BMC Cancer · 2023 · 20 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Novel cucurmosin‐based immunotoxin targeting programmed cell death 1‐ligand 1 with high potency against human tumor in vitro and in vivo

Caiyun Zhang, Jiani Xiong, Yinxiang Lan et al. · Cancer Science · 2020 · 19 citations · Full text

Medicine, Oncology, Pharmacology +17

An EGFR L858R mutation identified in 1862 Chinese NSCLC patients can be a promising neoantigen vaccine therapeutic strategy

Jing Lin, Jun Liu, Shiguang Hao et al. · Frontiers in Immunology · 2022 · 12 citations · Full text

Life Sciences, Molecular Biology, Oncology +17